Analyst ratings, especially from reputable firms like Needham, can significantly influence investor sentiment and stock prices. The reiteration of a Buy rating and maintenance of a high price target suggests a strong vote of confidence in Intra-Cellular Therapies' future performance, potentially leading to positive short-term price movement.